Advertisement

Topics

Genomic Profiling Systems Company Profile

09:18 EDT 26th September 2018 | BioPortfolio

Genomic Profiling Systems, Inc. (GPS) is developing pioneering products to address the significant need for rapid microbial and molecular analysis in industrial microbiology and healthcare. GPS's suite of technologies for detecting microbes and molecules provides tests that are rapid, quantitative and ultra-sensitive while being simple, user-friendly, and cost-effective to implement.

Location

One Oak Park Drive, 2nd Floor
Bedford
Massachusetts
01730
United States of America

Contact

Phone: 781-271-1444
Fax: 781-271-9905
Email: info@genprosys.com


News Articles [885 Associated News Articles listed on BioPortfolio]

Wamberg Genomic Advisors joins with the American Cancer Society to Drive Funds for Lifesaving ...

Cancer Guardian is an exclusive program that provides access to leading comprehensive genomic profiling at the time of a cancer diagnosis. Information from comprehensive genomic Read more...

Managing Ductal Carcinoma In Situ in the Era of Genomic Profiling

At the 2018 Miami Breast Cancer Conference, Dr. Patrick Borgen presented information related to gene expression profiling as a tool for managing DCIS.

Foundation Medicine and its Collaborators Present New Findings Supporting Comprehensive Genomic Profiling for Targeted Treatment

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc. (NASDAQ:FMI) today announced the presentation of new findings at the American Association for Cancer Research (AACR) Annual Meet...

Genomic and expression profiling reveal molecular heterogeneity of disseminated tumor cells in bone marrow of early breast cancer

Genomic and expression profiling reveal molecular heterogeneity of disseminated tumor cells in bone marrow of early breast cancerGenomic and expression profiling reveal molecular heterogeneity of diss...

Comprehensive genomic profiling aids in the identification of personalised therapeutic options

Findings from a recent study demonstrate that comprehensive genetic profiling (CGP) is a useful tool in directing patient care, including the identification of targeted therapies and enrollment in cli...

Press Release: Roche announces global availability of blood-based genomic profiling test, FoundationOne Liquid

F. Hoffmann-La Roche Ltd / Roche announces global availability of blood-based genomic profiling test, FoundationOne Liquid . Processed and transmitted by West Corporation. The issuer is solely res...

A reassessment of DNA-immunoprecipitation-based genomic profiling

FDA approves pan-tumour genomic profiling assay

PubMed Articles [2025 Associated PubMed Articles listed on BioPortfolio]

System wide analysis unravels differential regulation and in vivo essentiality of VapBC TA systems from Mycobacterium tuberculosis.

Toxin-antitoxin (TA) systems are bicistronic genetic modules that are ubiquitously present in bacterial genomes. Mycobacterium tuberculosis (Mtb) genome encodes for 90 putative TA systems and these ar...

Analytical validation of a hybrid capture-based next-generation sequencing clinical assay for genomic profiling of cell-free circulating tumor DNA.

Genomic profiling of circulating tumor DNA derived from cell-free DNA (cfDNA) in blood can provide a non-invasive method for the detection of genomic biomarkers to guide clinical decision-making for c...

DNA methylation profiling of genomic DNA isolated from urine in diabetic chronic kidney disease: A pilot study.

To characterise the genomic DNA (gDNA) yield from urine and quality of derived methylation data generated from the widely used Illuminia Infinium MethylationEPIC (HM850K) platform and compare this wit...

Using Genomic Sequencing to Improve Management in Melanoma.

Rapidly advancing genomic sequencing technologies are changing all areas of cancer, from diagnosis to surveillance, and prognostication to treatment. The role of genomic testing in melanoma is expandi...

Low clinical adoption of tumor genomic profiling: cause for concern?

Clinical Trials [1678 Associated Clinical Trials listed on BioPortfolio]

Advanced Cancer Patients Decision Making and Family Communication About Secondary Findings From Tumor Genomic Profiling

The objective of this protocol is to characterize advanced cancer patients' responses to learning their secondary findings arising from tumor genomic profiling, and the process and outcome...

Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer

The primary objective is to examine the impact on progression-free survival of targeted therapy for breast cancer suggested by proteomic and genomic profiling.

Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer

Overall survival rates for patients with metastatic NSCLC are poor utilizing conventional cytotoxic chemotherapy approaches. However, a subset of patients harbor genomic driver mutations, ...

Study to Assess the Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations

With the increased availability of next-generation sequencing, oncologists are starting to incorporate genomic profiling into routine care of cancer patients. If a genomic alteration is id...

Genomic Testing and Resulting Medical Decisions

There is no evidence available about which molecular profiling methods are currently used for cancer patients in Austrian clinical practice. The construction of the registry proposed as a ...

Companies [1706 Associated Companies listed on BioPortfolio]

Genomic Profiling Systems

Genomic Profiling Systems, Inc. (GPS) is developing pioneering products to address the significant need for rapid microbial and molecular analysis in industrial microbiology and healthcare. GPS's suit...

Genomic Health

Genomic Health gives cancer patients and physicians insight needed to help make quality treatment decisions. GenomicHealth.com is designed to help patients, caregivers and healthcare professionals und...

KEW, Inc.

KEW, Inc. is a privately-held comprehensive genomic profiling company with headquarters in Cambridge, MA, USA., dedicated to revolutionizing cancer care by providing therapeutic o...

Genomic Technologies

Genomic Technologies utilizes its proprietary instrument control software and well proven mechanical systems for rapid development of synthesis platforms ranging from analytical to preparative scale s...

Genomic Systems

Genomic Systems is a privately held start-up biotechnology company that is in-licensing, developing and commercializing novel targeted therapeutics that address serious unmet medi...

More Information about "Genomic Profiling Systems" on BioPortfolio

We have published hundreds of Genomic Profiling Systems news stories on BioPortfolio along with dozens of Genomic Profiling Systems Clinical Trials and PubMed Articles about Genomic Profiling Systems for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Genomic Profiling Systems Companies in our database. You can also find out about relevant Genomic Profiling Systems Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record